Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study

[1]  M. Treggiari,et al.  Association of Appropriate Empirical Antimicrobial Therapy With In-Hospital Mortality in Patients With Bloodstream Infections in the US , 2023, JAMA network open.

[2]  D. Lebeaux,et al.  Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. , 2021, Infectious diseases now.

[3]  K. Laupland,et al.  Burden of bloodstream infection in older persons: a population‐based study , 2021, BMC Geriatrics.

[4]  D. Breilh,et al.  Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When. , 2020, Journal of the American Medical Directors Association.

[5]  E. Denamur,et al.  Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it. , 2020, The Journal of antimicrobial chemotherapy.

[6]  M. Bonten,et al.  Short course aminoglycosides as adjunctive empiric therapy in patients with Gram-negative bloodstream infection, a cohort study. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  W. Ko,et al.  Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia , 2019, Critical Care.

[8]  J. Ouslander,et al.  Sepsis in Older Adults in Long‐Term Care Facilities: Challenges in Diagnosis and Management , 2019, Journal of the American Geriatrics Society.

[9]  M. Rainfray,et al.  Atypical presentation of bacteremia in older patients is a risk factor for death. , 2019, The American journal of medicine.

[10]  D. Yahav,et al.  Bloodstream infections in the elderly: what is the real goal? , 2019, Aging Clinical and Experimental Research.

[11]  R. Ferrer,et al.  Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study , 2019, Annals of Intensive Care.

[12]  L. Leibovici,et al.  Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Mervyn Singer,et al.  The new sepsis consensus definitions (Sepsis-3): the good, the not-so-bad, and the actually-quite-pretty , 2016, Intensive Care Medicine.

[14]  L. Leibovici,et al.  Bloodstream infections in older patients , 2016, Virulence.

[15]  G. Gavazzi,et al.  Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  R. Guy,et al.  Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  Á. Soriano,et al.  Clinical characteristics and outcome of elderly patients with community-onset bacteremia. , 2015, The Journal of infection.

[18]  M. Kollef,et al.  Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study , 2014, Critical Care.

[19]  L. Baddour,et al.  External validation of bloodstream infection mortality risk score in a population-based cohort. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  A. Del Arco,et al.  Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort. , 2014, International Journal of Infectious Diseases.

[21]  L. Leibovici,et al.  Long-term consequences of severe infections. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  Chien-Chang Lee,et al.  Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. , 2013, The Journal of antimicrobial chemotherapy.

[23]  W. Ko,et al.  Different impact of the appropriateness of empirical antibiotics for bacteremia among younger adults and the elderly in the ED. , 2013, The American journal of emergency medicine.

[24]  H. Wunsch,et al.  Population Burden of Long‐Term Survivorship After Severe Sepsis in Older Americans , 2012, Journal of the American Geriatrics Society.

[25]  B. Falissard,et al.  Mortality and bloodstream infections in geriatrics units. , 2010, Archives of gerontology and geriatrics.

[26]  Á. Soriano,et al.  Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. , 2009, The Journal of antimicrobial chemotherapy.

[27]  M. Banerjee,et al.  Staphylococcus aureus Bloodstream Infections: The Association Between Age and Mortality and Functional Status , 2008, Journal of the American Geriatrics Society.

[28]  S. Blot,et al.  Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. , 2007, The Journal of antimicrobial chemotherapy.

[29]  L. Baddour,et al.  Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. , 2007, Archives of internal medicine.

[30]  M. McBean,et al.  Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. , 2001, The Journal of infectious diseases.

[31]  D. Heyland,et al.  Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life , 2000, Critical care medicine.

[32]  Leibovici,et al.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.

[33]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[34]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.